A Study to Assess the Efficacy, Safety and Pharmacokinetics of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy (SMA)
Clinical trial NCT01839656 · COMPLETED
Trial details
- NCT number
- NCT01839656
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-08
- Primary completion
- 2017-08-21
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.